Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus

被引:22
作者
Wu, SC [1 ]
Huang, GYL [1 ]
机构
[1] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan
关键词
D O I
10.1021/bp010120q
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Inactivated mouse-brain-derived vaccines for Japanese encephalitis virus (JEV) have been used for many years. Recently, attempts have been made to employ cultured Vero cells to replace mouse brain tissues for developing cell-culture-derived vaccines that will be more suitable for worldwide usage. In this study, JEV replication processes in Vero and BHK cells and between stationary and microcarrier culture systems were investigated. Our results demonstrated that a stationary Vero cell culture system produced higher viral titers of JEV, including the Beijin-1 vaccine strain and the attenuated strain CH2195LA, than microcarrier culture did. BHK cells showed less significant differences in their replication kinetics between stationary and microcarrier cultures. Reducing serum concentration during infection led to an overall decrease of JEV production in Vero cells but an increase in BHK cells. By establishing a complete serum-free Vero cell culture, the microcarrier system resulted in a more than 4-log lowered yield compared to that of the stationary culture for JEV production. Thus, the stationary culture is the most efficient system for JEV production from cultured Vero cells.
引用
收藏
页码:124 / 128
页数:5
相关论文
共 24 条
  • [1] [Anonymous], 1998, Wkly Epidemiol Rec, V73, P337
  • [2] Berry JM, 1999, BIOTECHNOL BIOENG, V62, P12, DOI 10.1002/(SICI)1097-0290(19990105)62:1<12::AID-BIT2>3.0.CO
  • [3] 2-G
  • [4] BURKE DS, 1988, ARBOVIRUSES EPIDEMIO, P69
  • [5] Application of a serum-free medium for the growth of vero cells and the production of reovirus
    Butler, M
    Burgener, A
    Patrick, M
    Berry, M
    Moffatt, D
    Huzel, N
    Barnabé, N
    Coombs, K
    [J]. BIOTECHNOLOGY PROGRESS, 2000, 16 (05) : 854 - 858
  • [6] GRIFFITHS JB, 1982, DEV BIOL STAND, V50, P103
  • [7] PROTECTION AGAINST JAPANESE ENCEPHALITIS BY INACTIVATED VACCINES
    HOKE, CH
    NISALAK, A
    SANGAWHIPA, N
    JATANASEN, S
    LAORAKAPONGSE, T
    INNIS, BL
    KOTCHASENEE, SO
    GINGRICH, JB
    LATENDRESSE, J
    FUKAI, K
    BURKE, DS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) : 608 - 614
  • [8] Development of a mammalian cell (Vero) derived candidate influenza virus vaccine
    Kistner, O
    Barrett, PN
    Mundt, W
    Reiter, M
    Schober-Bendixen, S
    Dorner, F
    [J]. VACCINE, 1998, 16 (9-10) : 960 - 968
  • [9] Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains
    Kurane, I
    Takasaki, T
    [J]. VACCINE, 2000, 18 : 33 - 35
  • [10] LEVENBOOK IS, 2000, J BIOL STAND, V12, P391